Temporal and spatial resolution of type I and III interferon responses in vivo

Journal of Virology

Volumn 84, Issue 17, 2010, Pages 8626-8638

  Pulverer, Julia Elisabeth ^a   Rand, Ulfert ^a   Lienenklaus, Stefan ^a   Kugel, Daniela ^b   Ziȩtara, Natalia ^a   Kochs, Georg ^b   Naumann, Ronald ^c   Weiss, Siegfried ^a   Staeheli, Peter ^b   Hauser, Hansjörg ^a   Köster, Mario ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DOUBLE STRANDED RNA; FIREFLY LUCIFERASE; GAMMA INTERFERON; INTERFERON; LIPOPOLYSACCHARIDE; TYPE I INTERFERON; TYPE III INTERFERON; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IFNAR1 PROTEIN, MOUSE; MYXOVIRUS RESISTANCE PROTEINS;

ANIMAL EXPERIMENT; ARTICLE; GENE EXPRESSION; GENE INDUCTION; IMMUNE RESPONSE; IN VIVO STUDY; KIDNEY; KINETICS; LIVER; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; SPLEEN; TRANSGENIC MOUSE; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A; MALE; METABOLISM; MOUSE MUTANT; ORTHOMYXOVIRUS; PHYSIOLOGY; VIROLOGY; WHOLE BODY IMAGING;

ANIMALIA; MUS; MUS MUSCULUS;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; GTP-BINDING PROTEINS; HUMANS; INFLUENZA, HUMAN; INFLUENZAVIRUS A; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGAN SPECIFICITY; RECEPTOR, INTERFERON ALPHA-BETA; SPLEEN; THOGOTOVIRUS; WHOLE BODY IMAGING;

EID: 77956643985     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00303-10     Document Type: Article

References (50)

1. Ank, N., H. West, and S. R. Paludan. 2006. IFN-lambda: novel antiviral cytokines. J. Interferon Cytokine Res. 26:373-379.
2. Asano, A., H. K. Jin, and T. Watanabe. 2003. Mouse Mx2 gene: organization, mRNA expression and the role of the interferon-response promoter in its regulation. Gene 306:105-113.
3. Baig, E., and E. N. Fish. 2008. Distinct signature type I interferon responses are determined by the infecting virus and the target cell. Antivir. Ther. 13:409-422.
4. Biron, C. A. 2001. Interferons alpha and beta as immune regulators - A new look. Immunity 14:661-664.
5. Bogdan, C., J. Mattner, and U. Schleicher. 2004. The role of type I interferons in non-viral infections. Immunol. Rev. 202:33-48.
6. Colonna, M., A. Krug, and M. Cella. 2002. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 14:373-379.
7. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
8. de Veer, M. J., M. Holko, M. Frevel, E. Walker, S. Der, J. M. Paranjape, R. H. Silverman, and B. R. Williams. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912-920.
9. Doyle, S. E., H. Schreckhise, K. Khuu-Duong, K. Henderson, R. Rosler, H. Storey, L. Yao, H. Liu, F. Barahmand-pour, P. Sivakumar, C. Chan, C. Birks, D. Foster, C. H. Clegg, P. Wietzke-Braun, S. Mihm, and K. M. Klucher. 2006. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 44:896-906.
10. Dumoutier, L., A. Tounsi, T. Michiels, C. Sommereyns, S. V. Kotenko, and J. C. Renauld. 2004. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J. Biol. Chem. 279:32269-32274.
11. Galabru, J., N. Robert, C. Buffet-Janvresse, Y. Rivière, and A. G. Hovanessian. 1985. Continuous production of interferon in normal mice: effect of anti-interferon globulin, sex, age, strain and environment on the levels of 2-5A synthetase and p67K kinase. J. Gen. Virol. 66:711-718.
12. Gao, B., W. I. Jeong, and Z. Tian. 2008. Liver: an organ with predominant innate immunity. Hepatology 47:729-736. (Pubitemid 351280741)
13. Ge, D., J. Fellay, A. J. Thompson, J. S. Simon, K. V. Shianna, T. J. Urban, E. L. Heinzen, P. Qiu, A. H. Bertelsen, A. J. Muir, M. Sulkowski, J. G. McHutchison, and D. B. Goldstein. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399-401.
14. Geiss, G. K., V. S. Carter, Y. He, B. K. Kwieciszewski, T. Holzman, M. J. Korth, C. A. Lazaro, N. Fausto, R. E. Bumgarner, and M. G. Katze. 2003. Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J. Virol. 77:6367-6375.
15. Grimm, D., P. Staeheli, M. Hufbauer, I. Koerner, L. Martinez-Sobrido, A. Solorzano, A. Garcia-Sastre, O. Haller, and G. Kochs. 2007. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc. Natl. Acad. Sci. U. S. A. 104:6806-6811.
16. Hagmaier, K., S. Jennings, J. Buse, F. Weber, and G. Kochs. 2003. Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist. J. Virol. 77:2747-2752.
17. Haller, O., M. Acklin, and P. Staeheli. 1987. Influenza virus resistance of wild mice: wild-type and mutant Mx alleles occur at comparable frequencies. J. Interferon Res. 7:647-656.
18. Haller, O., G. Kochs, and F. Weber. 2007. Interferon, Mx, and viral counter-measures. Cytokine Growth Factor Rev. 18:425-433.
19. Haller, O., P. Staeheli, and G. Kochs. 2007. Interferon-induced Mx proteins in antiviral host defense. Biochimie 89:812-818. (Pubitemid 47001645)
20. Haller, O., S. Stertz, and G. Kochs. 2007. The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect. 9:1636-1643. (Pubitemid 350217083)
21. Hida, S., K. Ogasawara, K. Sato, M. Abe, H. Takayanagi, T. Yokochi, T. Sato, S. Hirose, T. Shirai, S. Taki, and T. Taniguchi. 2000. CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 13:643-655.
22. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777.
23. Honda, K., H. Yanai, A. Takaoka, and T. Taniguchi. 2005. Regulation of the type I IFN induction: a current view. Int. Immunol. 17:1367-1378.
24. Jaks, E., M. Gavutis, G. Uze, J. Martal, and J. Piehler. 2007. Differential receptor subunit affinities of type I interferons govern differential signal activation. J. Mol. Biol. 366:525-539.
25. Jennings, S., L. Martinez-Sobrido, A. Garcia-Sastre, F. Weber, and G. Kochs. 2005. Thogoto virus ML protein suppresses IRF3 function. Virology 331:63-72.
26. Kalie, E., D. A. Jaitin, Y. Podoplelova, J. Piehler, and G. Schreiber. 2008. The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities. J. Biol. Chem. 283:32925-32936.
27. Kawai, T., and S. Akira. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21:317-337.
28. Kochs, G., L. Martinez-Sobrido, S. Lienenklaus, S. Weiss, A. Garcia-Sastre, and P. Staeheli. 2009. Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. J. Gen. Virol. 90:2990-2994.
29. Kotenko, S. V., G. Gallagher, V. V. Baurin, A. Lewis-Antes, M. Shen, N. K. Shah, J. A. Langer, F. Sheikh, H. Dickensheets, and R. P. Donnelly. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77.
30. Kumagai, Y., O. Takeuchi, H. Kato, H. Kumar, K. Matsui, E. Morii, K. Aozasa, T. Kawai, and S. Akira. 2007. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 27:240-252.
31. Lienenklaus, S., M. Cornitescu, N. Zietara, M. Lyszkiewicz, N. Gekara, J. Jablonska, F. Edenhofer, K. Rajewsky, D. Bruder, M. Hafner, P. Staeheli, and S. Weiss. 2009. Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J. Immunol. 183:3229-3236.
32. Liu, Y. J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23:275-306.
33. Malmgaard, L. 2004. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 24:439-454.
34. Marie, I., J. E. Durbin, and D. E. Levy. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669.
35. Mordstein, M., G. Kochs, L. Dumoutier, J. C. Renauld, S. R. Paludan, K. Klucher, and P. Staeheli. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4:e1000151.
36. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
37. Oritani, K., P. W. Kincade, C. Zhang, Y. Tomiyama, and Y. Matsuzawa. 2001. Type I interferons and limitin: a comparison of structures, receptors, and functions. Cytokine Growth Factor Rev. 12:337-348.
38. Pestka, S., C. D. Krause, and M. R. Walter. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202:8-32.
39. Scheu, S., P. Dresing, and R. M. Locksley. 2008. Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc. Natl. Acad. Sci. U. S. A. 105:20416-20421.
40. Sheppard, P., W. Kindsvogel, W. Xu, K. Henderson, S. Schlutsmeyer, T. E. Whitmore, R. Kuestner, U. Garrigues, C. Birks, J. Roraback, C. Ostrander, D. Dong, J. Shin, S. Presnell, B. Fox, B. Haldeman, E. Cooper, D. Taft, T. Gilbert, F. J. Grant, M. Tackett, W. Krivan, G. McKnight, C. Clegg, D. Foster, and K. M. Klucher. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68.
41. Sommereyns, C., S. Paul, P. Staeheli, and T. Michiels. 2008. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 4:e1000017.
42. Staeheli, P., R. Grob, E. Meier, J. G. Sutcliffe, and O. Haller. 1988. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 8:4518-4523.
43. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
44. Takaoka, A., and T. Taniguchi. 2003. New aspects of IFN-alpha/beta signalling in immunity, oncogenesis and bone metabolism. Cancer Sci. 94:405-411.
45. Thomas, D. L., C. L. Thio, M. P. Martin, Y. Qi, D. Ge, C. O'Huigin, J. Kidd, K. Kidd, S. I. Khakoo, G. Alexander, J. J. Goedert, G. D. Kirk, S. M. Donfield, H. R. Rosen, L. H. Tobler, M. P. Busch, J. G. McHutchison, D. B. Goldstein, and M. Carrington. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798-801.
46. Thompson, A. J., and S. A. Locarnini. 2007. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol. Cell Biol. 85:435-445.
47. Uze, G., G. Schreiber, J. Piehler, and S. Pellegrini. 2007. The receptor of the type I interferon family. Curr. Top. Microbiol. Immunol. 316:71-95.
48. van Boxel-Dezaire, A. H., M. R. Rani, and G. R. Stark. 2006. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25:361-372.
49. Verhoeyen, E., H. Hauser, and D. Wirth. 2001. Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement. Hum. Gene Ther. 12:933-944.
50. Vintersten, K., G. Testa, R. Naumann, K. Anastassiadis, and A. F. Stewart. 2008. Bacterial artificial chromosome transgenesis through pronuclear injection of fertilized mouse oocytes. Methods Mol. Biol. 415:83-100.